× Industry Reports Services Press Release Contact us About us

Latin America Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In Situ Hybridization, Chips & Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification), Industry Analysis Report, Country Outlook (Brazil, Mexico, Argentina, Colombia, Chile, Peru), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Published Date: May 2019 | Publisher: Graphical Research Report ID: GR1174 | Delivery : PDF

Report Content

Chapter 1.  Methodology & Scope

1.1. Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters

1.2. Data sources                   

1.2.1.  Secondary

1.2.2.  Primary

Chapter 2.  Executive Summary

2.1. Latin America molecular diagnostics industry 3600 synopsis, 2013 – 2024

2.1.1.  Country trends

2.1.2.  Application trends

2.1.3.  Technology trends

Chapter 3.  Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Major factor analysis

3.3.1.  Drivers

3.3.1.1.  Technological advances and increasing awareness towards early disease diagnosis

3.3.1.2.  Escalating demand for POC diagnostics

3.3.1.3.  Increasing geriatric population

3.3.1.4.  Upward trend in prevalence of infectious disease

3.3.2.  Industry pitfalls and challenges

3.3.2.1.  Lack of clear and uniform regulatory framework

3.3.2.2.  Increasing cost of disease diagnosis

3.4. Porter’s analysis

3.5. Competition review, 2017

3.6. PEST analysis

Chapter 4. Latin America Molecular Diagnostics Market, By Application

4.1. Key trends in Latin America molecular diagnostics market, by application

4.2. Infectious disease

4.2.1.  Market estimates and forecast, 2013-2024 (USD Million)

4.2.2.  Flu

4.2.2.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.3.  RSV virus

4.2.3.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.4.  Tuberculosis

4.2.4.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.5.  Meningitis

4.2.5.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.6.  HIV market

4.2.6.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.7.  Hepatitis C

4.2.7.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.8.  Hepatitis B

4.2.8.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.9.  HPV

4.2.9.1.    Market estimates and forecast, 2013-2024 (USD Million)

4.2.10. STD

4.2.10.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

4.2.10.2.  Chlamydia

4.2.10.2.1.  Market estimates and forecast, 2013-2024 (USD Million)

4.2.10.3.  Gonorrhea

4.2.10.3.1.  Market estimates and forecast, 2013-2024 (USD Million)

4.2.10.4.  Others

4.2.10.4.1.  Market estimates and forecast, 2013-2024 (USD Million)

4.2.11. Dengue

4.2.11.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

4.2.12. H. Pylori

4.2.12.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

4.2.13. TORCH

4.2.13.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

4.2.14. Others

4.2.14.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

4.3. Blood screening

4.3.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

4.4. Genetic testing

4.4.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

4.5. Oncology testing

4.5.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

Chapter 5. Latin America Molecular Diagnostics Market, By Technology

5.1. Key trends in Latin America molecular diagnostics market, by technology

5.2. PCR

5.2.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

5.3. In situ hybridization

5.3.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

5.4. Chips & microarrays

5.4.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

5.5. Mass spectrometry

5.5.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

5.6. Sequencing

5.6.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

5.7. Isothermal amplification

5.7.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

5.8. Others

5.8.1.  Market estimates and forecast, 2013 – 2024 (USD Million)

Chapter 6. Latin America Molecular Diagnostics Market, By Country

6.1. Key trends in Latin America molecular diagnostics market, by country

6.2. Brazil

6.2.1. Market estimates and forecast, 2013 - 2024

6.2.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million)

6.2.2.1.   Market estimates and forecast, by infectious disease, 2013 - 2024 (USD Million)

6.2.2.1.1. Market estimates and forecast, by STDs, 2013 - 2024 (USD Million)

6.2.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)

6.3. Mexico

6.3.1. Market estimates and forecast, 2013 - 2024

6.3.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million)

6.3.2.1.   Market estimates and forecast, by infectious disease, 2013 - 2024 (USD Million)

6.3.2.1.1. Market estimates and forecast, by STDs, 2013 - 2024 (USD Million)

6.3.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)

6.4. Argentina

6.4.1. Market estimates and forecast, 2013 - 2024

6.4.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million)

6.4.2.1.   Market estimates and forecast, by infectious disease, 2013 - 2024 (USD Million)

6.4.2.1.1. Market estimates and forecast, by STDs, 2013 - 2024 (USD Million)

6.4.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)

6.5. Colombia

6.5.1. Market estimates and forecast, 2013 - 2024

6.5.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million)

6.5.2.1.   Market estimates and forecast, by infectious disease, 2013 - 2024 (USD Million)

6.5.2.1.1. Market estimates and forecast, by STDs, 2013 - 2024 (USD Million)

6.5.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)

6.6. Chile

6.6.1. Market estimates and forecast, 2013 - 2024

6.6.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million)

6.6.2.1.   Market estimates and forecast, by infectious disease, 2013 - 2024 (USD Million)

6.6.2.1.1. Market estimates and forecast, by STDs, 2013 - 2024 (USD Million)

6.6.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)

6.7. Peru

6.7.1. Market estimates and forecast, 2013 - 2024

6.7.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million)

6.7.2.1.   Market estimates and forecast, by infectious disease, 2013 - 2024 (USD Million)

6.7.2.1.1. Market estimates and forecast, by STDs, 2013 - 2024 (USD Million)

6.7.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)

6.8. Others

6.8.1. Market estimates and forecast, 2013 - 2024

6.8.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million)

6.8.2.1.   Market estimates and forecast, by infectious disease, 2013 - 2024 (USD Million)

6.8.2.1.1. Market estimates and forecast, by STDs, 2013 - 2024 (USD Million)

6.8.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)

Chapter 7.  Company Profiles

7.1. Abbott

7.1.1.   Business overview

7.1.2.   Financial data

7.1.3.   Product landscape

7.1.4.   Strategic outlook

7.2. Agilent

7.2.1.  Business overview

7.2.2.  Financial data

7.2.3.  Product landscape

7.2.4.  Strategic outlook

7.3. Analytik Jena

7.3.1.  Business overview

7.3.2.  Financial data

7.3.3.  Product landscape

7.3.4.  Strategic outlook

7.4. Becton, Dickinson and Company

7.4.1.  Business overview

7.4.2.  Financial data

7.4.3.  Product landscape

7.4.4.  Strategic outlook

7.5. Biocartis

7.5.1.  Business overview

7.5.2.  Financial data

7.5.3.  Product landscape

7.5.4.  Strategic outlook

7.6. BioFire Diagnostics

7.6.1.  Business overview

7.6.2.  Financial data

7.6.3.  Product landscape

7.6.4.  Strategic outlook

7.7. BioMérieux

7.7.1.  Business overview

7.7.2.  Financial data

7.7.3.  Product landscape

7.7.4.  Strategic outlook

7.8. Bio-Rad Laboratories

7.8.1.  Business overview

7.8.2.  Financial data

7.8.3.  Product landscape

7.8.4.  Strategic outlook

7.9. Danaher

7.9.1.  Business overview

7.9.2.  Financial data

7.9.3.  Product landscape

7.9.4.  Strategic outlook

7.10.  Genomic Health

7.10.1. Business overview

7.10.2. Financial data

7.10.3. Product landscape

7.10.4. Strategic outlook

Data Tables

TABLE 1.  Latin America market estimates, by country, (USD Mn), 2013 - 2017

TABLE 2.  Latin America market forecast, by country, (USD Mn), 2018 - 2024

TABLE 3.  Latin America market estimates, by application, (USD Mn), 2013 - 2017

TABLE 4.  Latin America market forecast, by application, (USD Mn), 2018 - 2024

TABLE 5.  Latin America market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 6.  Latin America market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 7.  Latin America market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 8.  Latin America market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 9.  Latin America market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 10.  Latin America market forecast, by technology, (USD Mn), 2018 - 2024

TABLE 11.  Competition review

TABLE 12.  Latin America equipment market estimates, (USD Mn), 2013 - 2017

TABLE 13.  Latin America equipment market forecast, (USD Mn), 2018 - 2024

TABLE 14.  Latin America infectious disease market estimates, (USD Mn), 2013 - 2017

TABLE 15.  Latin America infectious disease market forecast, (USD Mn), 2018 - 2024

TABLE 16.  Latin America flu market estimates, (USD Mn), 2013 - 2017

TABLE 17.  Latin America flu market forecast, (USD Mn), 2018 - 2024

TABLE 18.  Latin America RSV virus market estimates, (USD Mn), 2013 - 2017

TABLE 19.  Latin America RSV virus market forecast, (USD Mn), 2018 - 2024

TABLE 20.  Latin America tuberculosis market estimates, (USD Mn), 2013 - 2017

TABLE 21.  Latin America tuberculosis market forecast, (USD Mn), 2018 - 2024

TABLE 22.  Latin America meningitis market estimates, (USD Mn), 2013 - 2017

TABLE 23.  Latin America meningitis market forecast, (USD Mn), 2018 - 2024

TABLE 24.  Latin America HIV market estimates, (USD Mn), 2013 - 2017

TABLE 25.  Latin America HIV market forecast, (USD Mn), 2018 - 2024

TABLE 26.  Latin America hepatitis C market estimates, (USD Mn), 2013 - 2017

TABLE 27.  Latin America hepatitis C market forecast, (USD Mn), 2018 - 2024

TABLE 28.  Latin America hepatitis B market estimates, (USD Mn), 2013 - 2017

TABLE 29.  Latin America hepatitis B market forecast, (USD Mn), 2018 - 2024

TABLE 30.  Latin America HPV market estimates, (USD Mn), 2013 - 2017

TABLE 31.  Latin America HPV market forecast, (USD Mn), 2018 - 2024

TABLE 32.  Latin America STD market estimates, (USD Mn), 2013 - 2017

TABLE 33.  Latin America STD market forecast, (USD Mn), 2018 - 2024

TABLE 34.  Latin America chlamydia market estimates, (USD Mn), 2013 - 2017

TABLE 35.  Latin America chlamydia market forecast, (USD Mn), 2018 - 2024

TABLE 36.  Latin America gonorrhea market estimates, (USD Mn), 2013 - 2017

TABLE 37.  Latin America gonorrhea market forecast, (USD Mn), 2018 - 2024

TABLE 38.  Latin America others market estimates, (USD Mn), 2013 - 2017

TABLE 39.  Latin America others market forecast, (USD Mn), 2018 - 2024

TABLE 40.  Latin America dengue market estimates, (USD Mn), 2013 - 2017

TABLE 41.  Latin America dengue market forecast, (USD Mn), 2018 - 2024

TABLE 42.  Latin America H. pylori market estimates, (USD Mn), 2013 - 2017

TABLE 43.  Latin America H. pylori market forecast, (USD Mn), 2018 - 2024

TABLE 44.  Latin America TORCH market estimates, (USD Mn), 2013 - 2017

TABLE 45.  Latin America TORCH market forecast, (USD Mn), 2018 - 2024

TABLE 46.  Latin America others market estimates, (USD Mn), 2013 - 2017

TABLE 47.  Latin America others market forecast, (USD Mn), 2018 - 2024

TABLE 48.  Latin America blood screening market estimates, (USD Mn), 2013 - 2017

TABLE 49.  Latin America blood screening market forecast, (USD Mn), 2018 - 2024

TABLE 50.  Latin America genetic testing market estimates, (USD Mn), 2013 - 2017

TABLE 51.  Latin America genetic testing market forecast, (USD Mn), 2018 - 2024

TABLE 52.  Latin America oncology testing market estimates, (USD Mn), 2013 - 2017

TABLE 53.  Latin America oncology testing market forecast, (USD Mn), 2018 - 2024

TABLE 54.  Latin America PCR market estimates, (USD Mn), 2013 - 2017

TABLE 55.  Latin America PCR market forecast, (USD Mn), 2018 - 2024

TABLE 56.  Latin America in situ hybridization market estimates, (USD Mn), 2013 - 2017

TABLE 57.  Latin America in situ hybridization market forecast, (USD Mn), 2018 - 2024

TABLE 58.  Latin America chips & microarrays market estimates, (USD Mn), 2013 - 2017

TABLE 59.  Latin America chips & microarrays market forecast, (USD Mn), 2018 - 2024

TABLE 60.  Latin America mass spectrometry testing market estimates, (USD Mn), 2013 - 2017

TABLE 61.  Latin America mass spectrometry market forecast, (USD Mn), 2018 - 2024

TABLE 62.  Latin America sequencing market estimates, (USD Mn), 2013 - 2017

TABLE 63.  Latin America sequencing market forecast, (USD Mn), 2018 - 2024

TABLE 64.  Latin America isothermal amplification market estimates, (USD Mn), 2013 - 2017

TABLE 65.  Latin America isothermal amplification market forecast, (USD Mn), 2018 - 2024

TABLE 66.  Latin America others market estimates, (USD Mn), 2013 - 2017

TABLE 67.  Latin America others market forecast, (USD Mn), 2018 - 2024

TABLE 68.  Brazil molecular diagnostics market estimates, (USD Mn), 2013 - 2017

TABLE 69.  Brazil molecular diagnostics market forecast, (USD Mn), 2018 - 2024

TABLE 70.  Brazil molecular diagnostics market estimates, by application, (USD Mn), 2013 - 2017

TABLE 71.  Brazil molecular diagnostics market forecast, by application, (USD Mn), 2018 - 2024

TABLE 72.  Brazil molecular diagnostics market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 73.  Brazil molecular diagnostics market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 74.  Brazil molecular diagnostics market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 75.  Brazil molecular diagnostics market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 76.  Brazil molecular diagnostics market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 77.  Brazil molecular diagnostics market forecast, by technology, (USD Mn), 2018 – 2024

TABLE 78.  Mexico molecular diagnostics market estimates, (USD Mn), 2013 - 2017

TABLE 79.  Mexico molecular diagnostics market forecast, (USD Mn), 2018 - 2024

TABLE 80.  Mexico molecular diagnostics market estimates, by application, (USD Mn), 2013 - 2017

TABLE 81.  Mexico molecular diagnostics market forecast, by application, (USD Mn), 2018 - 2024

TABLE 82.  Mexico molecular diagnostics market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 83.  Mexico molecular diagnostics market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 84.  Mexico molecular diagnostics market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 85.  Mexico molecular diagnostics market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 86.  Mexico molecular diagnostics market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 87.  Mexico molecular diagnostics market forecast, by technology, (USD Mn), 2018 – 2024

TABLE 88.  Argentina molecular diagnostics market estimates, (USD Mn), 2013 - 2017

TABLE 89.  Argentina molecular diagnostics market forecast, (USD Mn), 2018 - 2024

TABLE 90.  Argentina molecular diagnostics market estimates, by application, (USD Mn), 2013 - 2017

TABLE 91.  Argentina molecular diagnostics market forecast, by application, (USD Mn), 2018 - 2024

TABLE 92.  Argentina molecular diagnostics market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 93.  Argentina molecular diagnostics market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 94.  Argentina molecular diagnostics market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 95.  Argentina molecular diagnostics market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 96.  Argentina molecular diagnostics market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 97.  Argentina molecular diagnostics market forecast, by technology, (USD Mn), 2018 – 2024

TABLE 98.  Colombia molecular diagnostics market estimates, (USD Mn), 2013 - 2017

TABLE 99.  Colombia molecular diagnostics market forecast, (USD Mn), 2018 - 2024

TABLE 100.  Colombia molecular diagnostics market estimates, by application, (USD Mn), 2013 - 2017

TABLE 101.  Colombia molecular diagnostics market forecast, by application, (USD Mn), 2018 - 2024

TABLE 102.  Colombia molecular diagnostics market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 103.  Colombia molecular diagnostics market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 104.  Colombia molecular diagnostics market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 105.  Colombia molecular diagnostics market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 106.  Colombia molecular diagnostics market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 107.  Colombia molecular diagnostics market forecast, by technology, (USD Mn), 2018 – 2024

TABLE 108.  Chile molecular diagnostics market estimates, (USD Mn), 2013 - 2017

TABLE 109.  Chile molecular diagnostics market forecast, (USD Mn), 2018 - 2024

TABLE 110.  Chile molecular diagnostics market estimates, by application, (USD Mn), 2013 - 2017

TABLE 111.  Chile molecular diagnostics market forecast, by application, (USD Mn), 2018 - 2024

TABLE 112.  Chile molecular diagnostics market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 113.  Chile molecular diagnostics market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 114.  Chile molecular diagnostics market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 115.  Chile molecular diagnostics market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 116.  Chile molecular diagnostics market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 117.  Chile molecular diagnostics market forecast, by technology, (USD Mn), 2018 – 2024

TABLE 118.  Peru molecular diagnostics market estimates, (USD Mn), 2013 - 2017

TABLE 119.  Peru molecular diagnostics market forecast, (USD Mn), 2018 - 2024

TABLE 120.  Peru molecular diagnostics market estimates, by application, (USD Mn), 2013 - 2017

TABLE 121.  Peru molecular diagnostics market forecast, by application, (USD Mn), 2018 - 2024

TABLE 122.  Peru molecular diagnostics market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 123.  Peru molecular diagnostics market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 124.  Peru molecular diagnostics market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 125.  Peru molecular diagnostics market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 126.  Peru molecular diagnostics market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 127.  Peru molecular diagnostics market forecast, by technology, (USD Mn), 2018 – 2024

TABLE 128.  Others molecular diagnostics market estimates, (USD Mn), 2013 - 2017

TABLE 129.  Others molecular diagnostics market forecast, (USD Mn), 2018 - 2024

TABLE 130.  Others molecular diagnostics market estimates, by application, (USD Mn), 2013 - 2017

TABLE 131.  Others molecular diagnostics market forecast, by application, (USD Mn), 2018 - 2024

TABLE 132.  Others molecular diagnostics market estimates, by infectious disease, (USD Mn), 2013 - 2017

TABLE 133.  Others molecular diagnostics market forecast, by infectious disease, (USD Mn), 2018 - 2024

TABLE 134.  Others molecular diagnostics market estimates, by STDs, (USD Mn), 2013 - 2017

TABLE 135.  Others molecular diagnostics market forecast, by STDs, (USD Mn), 2018 - 2024

TABLE 136.  Others molecular diagnostics market estimates, by technology, (USD Mn), 2013 - 2017

TABLE 137.  Others molecular diagnostics market forecast, by technology, (USD Mn), 2018 – 2024

Charts & Figures

FIG 1. Industry segmentation

FIG 2. Latin America molecular diagnostics market estimates and forecast, 2013 - 2024 (USD Million)

FIG 3. Porter’s analysis

FIG 4. PEST analysis

 


Select License

Latin America Molecular Diagnostics Market Analysis Report 2024


Related Reports
Why Choose us?
  • On-Time Delivery
  • Assured Quality
  • Industry Experts
  • Payment Security
Share Social-media